Skip to main content
Covering the operations of the oil and gas industry
General Interest
Refining & Processing
Drilling & Production
Exploration & Development
Pipelines & Transportation
Sections
General Interest
Refining & Processing
Drilling & Production
Exploration & Development
Pipelines & Transportation
LNG
Energy Transition
Industry Statistics
Members Only
Special
Webcasts
White Papers
Podcast
Magazine
Surveys
Research
Events
Submit an Article
Iran war
Contact
About Us
Subscribe
Newsletters
Advertise
Contact Us
Privacy Policy
Terms & Conditions
Affiliated Brands
OFFSHORE
ENERGYTECH
MICROGRID KNOWLEDGE
OGJ RESEARCH
Follow us on
http://www.facebook.com/ogjonline
https://www.linkedin.com/company/oil-&-gas-journal
http://twitter.com/ogjonline
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Helus Pharma
Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results
June 29, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering
June 25, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma™ Announces US$50 Million Underwritten Offering
June 24, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
June 24, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference
June 11, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York
June 01, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
April 30, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference
April 30, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
April 28, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan
April 23, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions
April 20, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer
April 20, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs
April 16, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer
March 12, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder
March 05, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee
February 24, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Nature Medicine Publishes Helus Pharma’s Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder
February 17, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights
February 13, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution
February 10, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq
January 05, 2026
From
Helus Pharma
Via
Business Wire
Tickers
CBOE
CYBN
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.